- Filed
- Feb 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 18, 2025 | 17.68M sh |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $324M |
| Short Term Debt | FY 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $12.15M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $302.58M |
| Current Assets | FY 2024 · Dec 31, 2023 | $400.46M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.26B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 20.75M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $120.39M |
| Capex | FY 2024 · Dec 31, 2022 | $12.55M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $85.4M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $3.64 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $3.73 |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $209.57M |
| Net Income | FY 2024 · Dec 31, 2022 | $75.55M |
| Operating Income | FY 2024 · Dec 31, 2022 | $99.76M |
| Revenue | FY 2024 · Dec 31, 2022 | $1.16B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $571.9M |